Back

The role of statins and SGLT2 inhibitors

20 June 2025 (00:00 - 00:00)
Organised by: Logo
Congress Presentation Part of: Optimising cardioprotection in patients with cancer Secondary Prevention CCO Premium Access ESC Cardio-Oncology 2025 Council of Cardio-Oncology

About the speaker

Photo
Doctor Marielle Scherrer-Crosbie

University of Pennsylvania, Philadelphia (United States of America)

3 More presentations in this session

Presentation thumbnail
Dexrazoxane and liposomal anthracyclines
Doctor A. Macedo (Sao Paulo, BR)
Slides Video
Presentation thumbnail
Integrating renin-angiotensin inhibitors, beta-blockers, and ARNIs
Doctor C. Plummer (Newcastle Upon Tyne, GB)
Slides Video
Presentation thumbnail
Optimising cardioprotection in cancer patients - discussion
Video

Access the full session

Session thumbnail
Optimising cardioprotection in patients with cancer

The Event

Event poster

ESC Cardio-Oncology 2025

20 June - 21 June 2025
You may be interested in
thumbnail
Congress Presentation
Indications for SGLT2i to prevent cardiovascular toxicity
thumbnail
Congress Presentation
Myocardial protection by novel treatment modalities
thumbnail
Congress Presentation
Dapagliflozin in primary prevention of cardiotoxicity induced by anthracycline-trastuzumab therapy through activation of pAMPK and inhibition of MyD88 and NLRP-3

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources